Arax Advisory Partners’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.93K	Buy	+621	New	+$2.93K	﹤0.01%	2430
2025 Q1	–	Sell	-9	Closed	-$44	–	3060
2024 Q4	$44	Sell	9 -1,918	-100%	-$9.38K	﹤0.01%	2404
2024 Q3	$9.04K	Hold	1,927	–	–	﹤0.01%	1462
2024 Q2	$10.9K	Buy	+1,927	New	+$10.9K	﹤0.01%	1227